Madana M Chilakuri, | |
1155 E Pershing Rd, Decatur, IL 62526-4726 | |
(217) 877-2374 | |
Not Available |
Full Name | Madana M Chilakuri |
---|---|
Gender | Male |
Speciality | Pharmacist |
Location | 1155 E Pershing Rd, Decatur, Illinois |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1609191279 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 051.293017 (Illinois) | Primary |
183500000X | Pharmacist | 14609-040 (Wisconsin) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Madana M Chilakuri, 2829 Glenarye Dr, Lindenhurst, IL 60046-7925 Ph: (207) 756-4065 | Madana M Chilakuri, 1155 E Pershing Rd, Decatur, IL 62526-4726 Ph: (217) 877-2374 |
News Archive
Mental health professionals from Weill Cornell Medical College in Qatar and the community highlighted the importance of mental health to overall physical health during a presentation Sunday as part of the medical college's recognition of World Mental Health Day.
The complete agenda for the Seventh International Chronic Total Occlusion (CTO) Summit is now available online at http://www.ctosummit.org/overview/agenda.html. The CTO Summit is a two-day conference featuring state-of-the-art technologies, research findings and new developments in therapeutic procedures essential for interventional cardiologists to optimize success in chronic total coronary occlusions.
New research led by physician-scientists at University of California, San Diego School of Medicine shows that the test most commonly used to screen pediatric patients for chronic liver disease is often incorrectly interpreted in many children's hospitals throughout the United States.
Use of the blood clot-inhibiting medication tifacogin does not appear to improve outcomes of patients with severe community-acquired pneumonia, according to a study conducted by researchers from North and South America, Europe, Asia and Africa. The drug had shown some potential benefit in the sCAP subgroup of an earlier trial involving sepsis patients.
CEL-SCI Corporation announced today that it has commenced its Phase III clinical trial for Multikine®, the Company's flagship immunotherapy, at the National Institute of Oncology in Budapest, Hungary. Enrollment is expected to start soon in this center. The study is already ongoing at twelve clinical sites in the United States, Canada, Poland and India.
› Verified 4 days ago
Ms. Halley Siedra Connor, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 625 W Pershing Rd, Decatur, IL 62526 Phone: 217-875-2751 Fax: 217-875-6631 | |
Kimberly Riggen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1315 N Water St, Decatur, IL 62526 Phone: 217-429-0958 | |
Dr. Jamie Leigh Hartman, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1595 E Cantrell St, Decatur, IL 62521 Phone: 217-429-4248 | |
Caleb David Braasch, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1818 South Airport Rd, Decatur, IL 62521 Phone: 217-864-5912 | |
Dr. Terance Moore, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1155 E Pershing Rd, Decatur, IL 62526 Phone: 217-877-2374 Fax: 217-877-0117 | |
Whitney Miller, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 225 East Ash Ave, Decatur, IL 62526 Phone: 217-872-1758 | |
Mr. David Mark Mattiuz, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1315 N Water St, Decatur, IL 62526 Phone: 217-429-0958 Fax: 217-429-1096 |